Cover Image
市場調查報告書

北美心血管介入設備市場預測

North America Interventional Cardiology Market Outlook to 2025

出版商 GlobalData 商品編碼 304784
出版日期 內容資訊 英文 231 Pages
訂單完成後即時交付
價格
Back to Top
北美心血管介入設備市場預測 North America Interventional Cardiology Market Outlook to 2025
出版日期: 2018年04月16日 內容資訊: 英文 231 Pages
簡介

本報告提供北美心血管介入設備市場相關資料,提供動脈切開、密合設備,心導管,冠狀動脈用導管導引線,冠狀動脈支架,血管內超音波檢查裝置(IVUS),PTCA球囊擴張術及PTCA冠狀動脈藥物釋放型球囊(DEB)等各類別銷售額,銷售數的實際成果及預測,平均價格,企業佔有率,流通佔有率,再彙整主要企業簡介,開發中產品,主要的財務相關交易等最新資訊。

第1章 目錄

第2章 簡介

  • 報告的內容
  • 心血管介入設備的區分
  • 該報告對象市場定義

第3章 北美心血管介入設備市場

  • 收益(實際成果與預測)
  • 各收益類別比較(實際成果與預測)
  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果與預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 企業佔有率:各收益

第4章 加拿大的心血管介入設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第5章 墨西哥的心血管介入設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第6章 美國的心血管介入設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第7章 主要企業概要

  • Boston Scientific Corporation
  • Abbott Laboratories
  • Medtronic, Inc.
  • Cordis Corporation
  • Terumo Corporation
  • Volcano Corporation
  • St. Jude Medical, Inc.

第8章 開發中產品

第9章 最新趨勢

  • 企業通訊
  • 財務發表
  • 政府·公益相關資訊
  • 法律規章
  • 其他重要的趨勢
  • 產品資訊
  • 研究開發
  • 策略及產業規劃

第10章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECR0799DB

GlobalData's new report, "North America Interventional Cardiology Market Outlook to 2025", provides key market data on the North America Interventional Cardiology market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments -Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons Catheters and PTCA Drug Eluting Balloon (DEB) Catheters.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Interventional Cardiology market segments - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons Catheters and PTCA Drug Eluting Balloon (DEB) Catheters.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Interventional Cardiology market.
  • Global corporate-level profiles of key companies operating within the North America Interventional Cardiology market.
  • Key players covered include Abbott Laboratories, Boston Scientific Corp, Medtronic plc, and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 7
  • 1.2 List of Figures 8

2 Introduction 10

  • 2.1 What Is This Report About? 10
  • 2.2 Interventional Cardiology Market Segmentation 10
  • 2.3 Definitions of Markets Covered in the Report 11

3 Interventional Cardiology Market, North America 15

  • 3.1 Interventional Cardiology Market, North America, Revenue ($m), 2015-2025 15
  • 3.2 Interventional Cardiology Market, North America, Revenue ($m), 2015-2025 17
  • 3.3 Interventional Cardiology Market, North America, Volume (Units), 2015-2025 20
  • 3.4 Interventional Cardiology Market, North America, Volume (Units), 2015-2025 22
  • 3.5 Interventional Cardiology Market, North America, Company Share by Revenue ($m), 2017 25

4 Interventional Cardiology Market, Canada 27

  • 4.1 Interventional Cardiology Market, Canada, Revenue ($m), 2015-2025 27
    • 4.1.1 Arteriotomy Closure Devices Market, Canada, Revenue ($m), by Segment, 2015-2025 30
    • 4.1.2 Cardiac Catheters Market, Canada, Revenue ($m), by Segment, 2015-2025 32
    • 4.1.3 Coronary Stents Market, Canada, Revenue ($m), by Segment, 2015-2025 34
    • 4.1.4 Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), by Segment, 2015-2025 37
    • 4.1.5 PTCA Balloons Catheters Market, Canada, Revenue ($m), by Segment, 2015-2025 39
  • 4.2 Interventional Cardiology Market, Canada, Volume (Units), 2015-2025 41
    • 4.2.1 Arteriotomy Closure Devices Market, Canada, Volume (Units), by Segment, 2015-2025 44
    • 4.2.2 Cardiac Catheters Market, Canada, Volume (Units), by Segment, 2015-2025 46
    • 4.2.3 Coronary Stents Market, Canada, Volume (Units), by Segment, 2015-2025 48
    • 4.2.4 Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), by Segment, 2015-2025 51
    • 4.2.5 PTCA Balloons Catheters Market, Canada, Volume (Units), by Segment, 2015-2025 53
  • 4.3 Interventional Cardiology Market, Canada, Average Price ($), 2015-2025 55
  • 4.4 Interventional Cardiology Market, Canada, Distribution Share by Revenue ($m), 2017 59
  • 4.5 Interventional Cardiology Market, Canada, Company Share by Revenue ($m), 2017 60

5 Interventional Cardiology Market, Mexico 62

  • 5.1 Interventional Cardiology Market, Mexico, Revenue ($m), 2015-2025 62
    • 5.1.1 Arteriotomy Closure Devices Market, Mexico, Revenue ($m), by Segment, 2015-2025 65
    • 5.1.2 Cardiac Catheters Market, Mexico, Revenue ($m), by Segment, 2015-2025 67
    • 5.1.3 Coronary Stents Market, Mexico, Revenue ($m), by Segment, 2015-2025 69
    • 5.1.4 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), by Segment, 2015-2025 72
    • 5.1.5 PTCA Balloons Catheters Market, Mexico, Revenue ($m), by Segment, 2015-2025 74
  • 5.2 Interventional Cardiology Market, Mexico, Volume (Units), 2015-2025 76
    • 5.2.1 Arteriotomy Closure Devices Market, Mexico, Volume (Units), by Segment, 2015-2025 79
    • 5.2.2 Cardiac Catheters Market, Mexico, Volume (Units), by Segment, 2015-2025 81
    • 5.2.3 Coronary Stents Market, Mexico, Volume (Units), by Segment, 2015-2025 83
    • 5.2.4 Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), by Segment, 2015-2025 86
    • 5.2.5 PTCA Balloons Catheters Market, Mexico, Volume (Units), by Segment, 2015-2025 88
  • 5.3 Interventional Cardiology Market, Mexico, Average Price ($), 2015-2025 90
  • 5.4 Interventional Cardiology Market, Mexico, Distribution Share by Revenue ($m), 2017 94
  • 5.5 Interventional Cardiology Market, Mexico, Company Share by Revenue ($m), 2017 95

6 Interventional Cardiology Market, United States 97

  • 6.1 Interventional Cardiology Market, United States, Revenue ($m), 2015-2025 97
    • 6.1.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2015-2025 100
    • 6.1.2 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 102
    • 6.1.3 Coronary Stents Market, United States, Revenue ($m), by Segment, 2015-2025 104
    • 6.1.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2015-2025 107
    • 6.1.5 PTCA Balloons Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 109
  • 6.2 Interventional Cardiology Market, United States, Volume (Units), 2015-2025 111
    • 6.2.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2015-2025 114
    • 6.2.2 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2015-2025 116
    • 6.2.3 Coronary Stents Market, United States, Volume (Units), by Segment, 2015-2025 118
    • 6.2.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2015-2025 121
    • 6.2.5 PTCA Balloons Catheters Market, United States, Volume (Units), by Segment, 2015-2025 123
  • 6.3 Interventional Cardiology Market, United States, Average Price ($), 2015-2025 125
  • 6.4 Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), 2017 129
  • 6.5 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2017 130

7 Overview of Key Companies in North America Interventional Cardiology Market 132

  • 7.1 Boston Scientific Corp 132
    • 7.1.1 Company Overview 132
  • 7.2 Abbott Laboratories 132
    • 7.2.1 Company Overview 132
  • 7.3 Medtronic Plc 132
    • 7.3.1 Company Overview 132
  • 7.4 Terumo Corp 132
    • 7.4.1 Company Overview 132
  • 7.5 Cook Medical Inc 133
    • 7.5.1 Company Overview 133
  • 7.6 Philips Healthcare 133
    • 7.6.1 Company Overview 133
  • 7.7 Asahi Kasei Corp 133
    • 7.7.1 Company Overview 133
  • 7.8 Cardinal Health Inc 133
    • 7.8.1 Company Overview 133

8 Interventional Cardiology Market Pipeline Products 134

9 Recent Developments 137

  • 9.1 Corporate Communications 137
    • 9.1.1 Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 137
    • 9.1.2 Feb 27, 2018: Z-Medica Announces Appointment Of Eric Compton As CEO 137
    • 9.1.3 Feb 21, 2018: Endologix Announces Resignation Of John McDermott As Chief Executive Officer 137
    • 9.1.4 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman 138
    • 9.1.5 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 138
    • 9.1.6 Feb 02, 2018: Cardiovascular Systems Appoints Jeff Points as Chief Financial Officer 139
    • 9.1.7 Jan 29, 2018: Endologix Names Greg Morrow As Chief Marketing Officer 139
    • 9.1.8 Jan 29, 2018: Endologix Appoints Greg Morrow as Chief Marketing Officer 140
    • 9.1.9 Jan 24, 2018: Cardiovascular Systems Appoints Rhonda Robb as New Chief Operating Officer 140
    • 9.1.10 Jan 22, 2018: Neovasc Appoints Fred Colen As Chief Executive Officer 141
    • 9.1.11 Jan 03, 2018: Tryton Medical Announces New CEO and President 142
    • 9.1.12 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 142
    • 9.1.13 Nov 22, 2017: IMRIS Appoints Mark Strong as Senior Vice President - Research & Development 142
    • 9.1.14 Nov 20, 2017: Follicum applies for the start of a Phase II study at the German Medicines Agency 143
    • 9.1.15 Oct 31, 2017: Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay 143
    • 9.1.16 Oct 19, 2017: Endologix Appoints John Onopchenko as Chief Operating Officer 145
    • 9.1.17 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 145
    • 9.1.18 Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors 146
    • 9.1.19 Sep 26, 2017: Edward Parent Appointed Director of Quality Assurance at TissueGen 146
    • 9.1.20 Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 147
    • 9.1.21 Aug 08, 2017: John K. Bakewell Joins Corindus Vascular Robotics Board of Directors 147
    • 9.1.22 Jul 31, 2017: Atara Biotherapeutics Announces Two Presentations at MSParis2017, Including Updated, Interim Results from a Phase 1 Study of Autologous ATA188 in Patients with Progressive Multiple Sclerosis 148
    • 9.1.23 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer 149
    • 9.1.24 Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer 149
    • 9.1.25 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants Joins Osprey Board 150
    • 9.1.26 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants J oins Osprey Board 150
    • 9.1.27 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 151
    • 9.1.28 May 26, 2017: Merit Medical Announces Appointment of New Director 151
    • 9.1.29 Apr 19, 2017: TissueGen appoints New Faces for Growing Sales Team 151
  • 9.2 Financial Announcements 152
    • 9.2.1 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results 152
    • 9.2.2 Mar 28, 2018: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017 153
    • 9.2.3 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results 155
    • 9.2.4 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results 156
    • 9.2.5 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results 157
    • 9.2.6 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017 158
    • 9.2.7 Feb 21, 2018: Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results 159
    • 9.2.8 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017 160
    • 9.2.9 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 160
    • 9.2.10 Feb 07, 2018: Cardiovascular Systems Reports Fiscal 2018 Second-Quarter Financial Results 161
    • 9.2.11 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 162
    • 9.2.12 Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year 164
    • 9.2.13 Jan 23, 2018: Glytec's Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technology 164
    • 9.2.14 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 166
    • 9.2.15 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017 166
    • 9.2.16 Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year 166
    • 9.2.17 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 167
    • 9.2.18 Dec 12, 2017: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting 168
    • 9.2.19 Nov 14, 2017: Neovasc Announces Results for the Third Quarter of 2017 169
    • 9.2.20 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance 171
    • 9.2.21 Nov 07, 2017: Endologix Reports Third Quarter 2017 Financial Results 172
    • 9.2.22 Nov 07, 2017: Corindus Vascular Robotics Reports Third Quarter 2017 Results 173
    • 9.2.23 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results 173
    • 9.2.24 Oct 31, 2017: Abbott Announces FDA Clearance for its Alinity ci-series Next-generation Diagnostic Systems 174
    • 9.2.25 Oct 31, 2017: Northwell expands technology that precisely targets breast tumors 176
    • 9.2.26 Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results 178
    • 9.2.27 Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% 180
    • 9.2.28 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 180
    • 9.2.29 Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results 182
    • 9.2.30 Oct 25, 2017: Cardiovascular Systems Reports Fiscal 2018 First-Quarter Financial Results 183
    • 9.2.31 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017 184
    • 9.2.32 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results 185
    • 9.2.33 Aug 15, 2017: CareRay Exhibits At FIME 2017 186
    • 9.2.34 Aug 10, 2017: Neovasc Announces Results for the Second Quarter of 2017 187
    • 9.2.35 Aug 08, 2017: Corindus Vascular Robotics Reports Second Quarter 2017 Results 189
    • 9.2.36 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance 190
    • 9.2.37 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 190
    • 9.2.38 Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results 191
    • 9.2.39 Aug 02, 2017: Endologix Reports Second Quarter 2017 Financial Results 192
    • 9.2.40 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 193
    • 9.2.41 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results 194
    • 9.2.42 Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year 195
    • 9.2.43 Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results 196
    • 9.2.44 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 197
    • 9.2.45 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 198
    • 9.2.46 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 199
    • 9.2.47 May 10, 2017: Neovasc Announces Results for the First Quarter of 2017 200
    • 9.2.48 May 09, 2017: Corindus Vascular Robotics Reports First Quarter 2017 Results 202
    • 9.2.49 May 08, 2017: Integer Holdings Reports First Quarter 2017 Results 203
    • 9.2.50 May 04, 2017: AtriCure Reports First Quarter 2017 Financial Results 204
    • 9.2.51 May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year 204
    • 9.2.52 May 04, 2017: Endologix Reports First Quarter 2017 Financial Results 205
    • 9.2.53 May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results 206
    • 9.2.54 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 207
    • 9.2.55 Apr 27, 2017: Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance 208
    • 9.2.56 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 209
    • 9.2.57 Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million 210
    • 9.2.58 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 210
    • 9.2.59 Apr 20, 2017: bioMerieux: The FilmArray Respiratory Panel 2 plus (RP2plus) Gets CE Marked 211
    • 9.2.60 Apr 17, 2017: Lixte Biotechnology's Protein Phosphatase 2A Inhibitor, LB-100, Reported to be a Potentiator of Immunotherapy in an Animal Model 213
    • 9.2.61 Apr 17, 2017: Surmodics Appoints Lisa Wipperman Heine to Its Board of Directors 214
  • 9.3 Government and Public Interest 214
    • 9.3.1 Apr 03, 2018: Important JAMA Article Underscores Superiority of Precipio's Liquid Biopsy Core Technology 214
    • 9.3.2 Jul 19, 2017: NIDEK's Me1200 won the "Ponts d'Or" award in France 215
  • 9.4 Legal And Regulatory 216
    • 9.4.1 Mar 13, 2018: Precipio Settles Lawsuit with Crede Capital 216
    • 9.4.2 Nov 03, 2017: Neovasc Provides Litigation Update 217
    • 9.4.3 Oct 18, 2017: Loxo Oncology Announces Positive Top-Line Results from Independent Review Committee Assessment of Larotrectinib Dataset 217
    • 9.4.4 Sep 07, 2017: Ignyta To Host Conference Call And Live Webcast On September 11 To Provide Pipeline Review, Including Lead Candidate Entrectinib 218
  • 9.5 Other Significant Developments 218
    • 9.5.1 Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives 218
    • 9.5.2 Feb 08, 2018: IMRIS Reports Continued Strong Growth in 2017 219
    • 9.5.3 Sep 18, 2017: Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma 220
    • 9.5.4 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 220
    • 9.5.5 Apr 25, 2017: AtriCure's AtriClip System Surpasses 100,000 Units Sold Worldwide 221
  • 9.6 Product News 222
    • 9.6.1 Jan 02, 2018: Corindus to Participate with Mayo Clinic in Preclinical Study of Remote Control Robotics for Percutaneous Coronary Interventions Remote Treatment Capabilities 222
    • 9.6.2 Oct 10, 2017: Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids 223
  • 9.7 Strategy And Business Planning 224
    • 9.7.1 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 224

10 Appendix 225

  • 10.1 Research Methodology 226
    • 10.1.1 Coverage 226
    • 10.1.2 Secondary Research 226
    • 10.1.3 Primary Research 227
    • 10.1.4 Market Modeling and Forecasting 228
    • 10.1.5 Company Share Analysis 229
    • 10.1.6 Distribution Share Analysis 230
    • 10.1.7 Benchmarking 230
  • 10.2 GlobalData Consulting 230
  • 10.3 Contact Us 231
  • 10.4 Disclaimer 231

List of Tables

1.1 List of Tables

  • Table 1: Interventional Cardiology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 16
  • Table 2: Interventional Cardiology Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020 18
  • Table 3: Interventional Cardiology Market, North America, Revenue ($m), Forecast, USD Constant, 2021-2025 19
  • Table 4: Interventional Cardiology Market, North America, Volume (Units), 2015-2025 21
  • Table 5: Interventional Cardiology Market, North America, Volume (Units), 2015-2020 23
  • Table 6: Interventional Cardiology Market, North America, Volume (Units), 2021-2025 24
  • Table 7: Interventional Cardiology Market, North America, Company Share by Revenue ($m), USD Constant, 2017 26
  • Table 8: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, 2015-2020 28
  • Table 9: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, 2021-2025 29
  • Table 10: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, 2015-2020 31
  • Table 11: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, 2021-2025 31
  • Table 12: Cardiac Catheters Market, Canada, Revenue ($m), USD Constant, 2015-2020 33
  • Table 13: Cardiac Catheters Market, Canada, Revenue ($m), USD Constant, 2021-2025 33
  • Table 14: Coronary Stents Market, Canada, Revenue ($m), USD Constant, 2015-2020 35
  • Table 15: Coronary Stents Market, Canada, Revenue ($m), USD Constant, 2021-2025 36
  • Table 16: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, 2015-2020 38
  • Table 17: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, 2021-2025 38
  • Table 18: PTCA Balloons Catheters Market, Canada, Revenue ($m), USD Constant, 2015-2020 40
  • Table 19: PTCA Balloons Catheters Market, Canada, Revenue ($m), USD Constant, 2021-2025 40
  • Table 20: Interventional Cardiology Market, Canada, Volume (Units), 2015-2020 42
  • Table 21: Interventional Cardiology Market, Canada, Volume (Units), 2021-2025 43
  • Table 22: Arteriotomy Closure Devices Market, Canada, Volume (Units), 2015-2020 45
  • Table 23: Arteriotomy Closure Devices Market, Canada, Volume (Units), 2021-2025 45
  • Table 24: Cardiac Catheters Market, Canada, Volume (Units), 2015-2020 47
  • Table 25: Cardiac Catheters Market, Canada, Volume (Units), 2021-2025 47
  • Table 26: Coronary Stents Market, Canada, Volume (Units), 2015-2020 49
  • Table 27: Coronary Stents Market, Canada, Volume (Units), 2021-2025 50
  • Table 28: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), 2015-2020 52
  • Table 29: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), 2021-2025 52
  • Table 30: PTCA Balloons Catheters Market, Canada, Volume (Units), 2015-2020 54
  • Table 31: PTCA Balloons Catheters Market, Canada, Volume (Units), 2021-2025 54
  • Table 32: Interventional Cardiology Market, Canada, Average Price ($), 2015-2020 55
  • Table 33: Interventional Cardiology Market, Canada, Average Price ($), 2021-2025 57
  • Table 34: Interventional Cardiology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 59
  • Table 35: Interventional Cardiology Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 61
  • Table 36: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, 2015-2020 63
  • Table 37: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, 2021-2025 64
  • Table 38: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2020 66
  • Table 39: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, 2021-2025 66
  • Table 40: Cardiac Catheters Market, Mexico, Revenue ($m), USD Constant, 2015-2020 68
  • Table 41: Cardiac Catheters Market, Mexico, Revenue ($m), USD Constant, 2021-2025 68
  • Table 42: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, 2015-2020 70
  • Table 43: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, 2021-2025 71
  • Table 44: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, 2015-2020 73
  • Table 45: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, 2021-2025 73
  • Table 46: PTCA Balloons Catheters Market, Mexico, Revenue ($m), USD Constant, 2015-2020 75
  • Table 47: PTCA Balloons Catheters Market, Mexico, Revenue ($m), USD Constant, 2021-2025 75
  • Table 48: Interventional Cardiology Market, Mexico, Volume (Units), 2015-2020 77
  • Table 49: Interventional Cardiology Market, Mexico, Volume (Units), 2021-2025 78
  • Table 50: Arteriotomy Closure Devices Market, Mexico, Volume (Units), 2015-2020 80
  • Table 51: Arteriotomy Closure Devices Market, Mexico, Volume (Units), 2021-2025 80
  • Table 52: Cardiac Catheters Market, Mexico, Volume (Units), 2015-2020 82
  • Table 53: Cardiac Catheters Market, Mexico, Volume (Units), 2021-2025 82
  • Table 54: Coronary Stents Market, Mexico, Volume (Units), 2015-2020 84
  • Table 55: Coronary Stents Market, Mexico, Volume (Units), 2021-2025 85
  • Table 56: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), 2015-2020 87
  • Table 57: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), 2021-2025 87
  • Table 58: PTCA Balloons Catheters Market, Mexico, Volume (Units), 2015-2020 89
  • Table 59: PTCA Balloons Catheters Market, Mexico, Volume (Units), 2021-2025 89
  • Table 60: Interventional Cardiology Market, Mexico, Average Price ($), 2015-2020 90
  • Table 61: Interventional Cardiology Market, Mexico, Average Price ($), 2021-2025 92
  • Table 62: Interventional Cardiology Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 94
  • Table 63: Interventional Cardiology Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 96
  • Table 64: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2015-2020 98
  • Table 65: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2021-2025 99
  • Table 66: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 101
  • Table 67: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 101
  • Table 68: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020 103
  • Table 69: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025 103
  • Table 70: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2015-2020 105
  • Table 71: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2021-2025 106
  • Table 72: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2015-2020 108
  • Table 73: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2021-2025 108
  • Table 74: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020 110
  • Table 75: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025 110
  • Table 76: Interventional Cardiology Market, United States, Volume (Units), 2015-2020 112
  • Table 77: Interventional Cardiology Market, United States, Volume (Units), 2021-2025 113
  • Table 78: Arteriotomy Closure Devices Market, United States, Volume (Units), 2015-2020 115
  • Table 79: Arteriotomy Closure Devices Market, United States, Volume (Units), 2021-2025 115
  • Table 80: Cardiac Catheters Market, United States, Volume (Units), 2015-2020 117
  • Table 81: Cardiac Catheters Market, United States, Volume (Units), 2021-2025 117
  • Table 82: Coronary Stents Market, United States, Volume (Units), 2015-2020 119
  • Table 83: Coronary Stents Market, United States, Volume (Units), 2021-2025 120
  • Table 84: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2015-2020 122
  • Table 85: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2021-2025 122
  • Table 86: PTCA Balloons Catheters Market, United States, Volume (Units), 2015-2020 124
  • Table 87: PTCA Balloons Catheters Market, United States, Volume (Units), 2021-2025 124
  • Table 88: Interventional Cardiology Market, United States, Average Price ($), 2015-2020 125
  • Table 89: Interventional Cardiology Market, United States, Average Price ($), 2021-2025 127
  • Table 90: Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 129
  • Table 91: Interventional Cardiology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 131
  • Table 92: Interventional Cardiology Market Pipeline Products 134
  • Table 93: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 228

List of Figures

1.2 List of Figures

  • Figure 1: Interventional Cardiology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 15
  • Figure 2: Interventional Cardiology Market, North America, Revenue ($m), Historic, USD Constant, 2015-2025 17
  • Figure 3: Interventional Cardiology Market, North America, Volume (Units), 2015-2025 20
  • Figure 4: Interventional Cardiology Market, North America, Volume (Units), 2015-2025 22
  • Figure 5: Interventional Cardiology Market, North America, Company Share (%) 2017 25
  • Figure 6: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, 2015-2025 27
  • Figure 7: Arteriotomy Closure Devices Market, Canada, Revenue ($m), USD Constant, 2015-2025 30
  • Figure 8: Cardiac Catheters Market, Canada, Revenue ($m), USD Constant, 2015-2025 32
  • Figure 9: Coronary Stents Market, Canada, Revenue ($m), USD Constant, 2015-2025 34
  • Figure 10: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, 2015-2025 37
  • Figure 11: PTCA Balloons Catheters Market, Canada, Revenue ($m), USD Constant, 2015-2025 39
  • Figure 12: Interventional Cardiology Market, Canada, Volume (Units), 2015-2025 41
  • Figure 13: Arteriotomy Closure Devices Market, Canada, Volume (Units), 2015-2025 44
  • Figure 14: Cardiac Catheters Market, Canada, Volume (Units), 2015-2025 46
  • Figure 15: Coronary Stents Market, Canada, Volume (Units), 2015-2025 48
  • Figure 16: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), 2015-2025 51
  • Figure 17: PTCA Balloons Catheters Market, Canada, Volume (Units), 2015-2025 53
  • Figure 18: Interventional Cardiology Market, Canada, Company Share (%) 2017 60
  • Figure 19: Interventional Cardiology Market, Mexico, Revenue ($m), USD Constant, 2015-2025 62
  • Figure 20: Arteriotomy Closure Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2025 65
  • Figure 21: Cardiac Catheters Market, Mexico, Revenue ($m), USD Constant, 2015-2025 67
  • Figure 22: Coronary Stents Market, Mexico, Revenue ($m), USD Constant, 2015-2025 69
  • Figure 23: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Revenue ($m), USD Constant, 2015-2025 72
  • Figure 24: PTCA Balloons Catheters Market, Mexico, Revenue ($m), USD Constant, 2015-2025 74
  • Figure 25: Interventional Cardiology Market, Mexico, Volume (Units), 2015-2025 76
  • Figure 26: Arteriotomy Closure Devices Market, Mexico, Volume (Units), 2015-2025 79
  • Figure 27: Cardiac Catheters Market, Mexico, Volume (Units), 2015-2025 81
  • Figure 28: Coronary Stents Market, Mexico, Volume (Units), 2015-2025 83
  • Figure 29: Intravascular Ultrasound Systems (IVUS) Market, Mexico, Volume (Units), 2015-2025 86
  • Figure 30: PTCA Balloons Catheters Market, Mexico, Volume (Units), 2015-2025 88
  • Figure 31: Interventional Cardiology Market, Mexico, Company Share (%) 2017 95
  • Figure 32: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2015-2025 97
  • Figure 33: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 100
  • Figure 34: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025 102
  • Figure 35: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2015-2025 104
  • Figure 36: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2015-2025 107
  • Figure 37: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025 109
  • Figure 38: Interventional Cardiology Market, United States, Volume (Units), 2015-2025 111
  • Figure 39: Arteriotomy Closure Devices Market, United States, Volume (Units), 2015-2025 114
  • Figure 40: Cardiac Catheters Market, United States, Volume (Units), 2015-2025 116
  • Figure 41: Coronary Stents Market, United States, Volume (Units), 2015-2025 118
  • Figure 42: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2015-2025 121
  • Figure 43: PTCA Balloons Catheters Market, United States, Volume (Units), 2015-2025 123
  • Figure 44: Interventional Cardiology Market, United States, Company Share (%) 2017 130
Back to Top